Rediscovery Life Sciences
Charleston
About Rediscovery Life Sciences
Rediscovery Life Sciences is a biopharma company that develops medicines with less risk through drug repurposing. It has various drug repurposing programs queued up, the first of which is RLS-003, a drug to treat Acute Kidney Injury (AKI).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $5.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2020)
- Website: rediscoveryls.com
- Phone: (703)915-4493
Industries & Categories
Biopharma, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/rediscovery-life-sciences-117117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.